| Revista: | Revista médica de Chile |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000448924 |
| ISSN: | 0034-9887 |
| Autores: | Ramírez Guerrero, Gonzalo1 Baghetti Hernández, Romyna1 Godoy Tello, Cristian1 Villagrán Cortés, Francisco1 Torres Cifuentes, Vicente1 Garay Coloma, Osvaldo1 |
| Instituciones: | 1Hospital Carlos Van Buren, Unidad de Cuidados Críticos, Valparaíso. Chile |
| Año: | 2022 |
| Volumen: | 150 |
| Número: | 2 |
| Paginación: | 266-270 |
| País: | Chile |
| Idioma: | Español |
| Tipo de documento: | Artículo |
| Enfoque: | Caso clínico |
| Resumen en inglés | Sepsis is one of the leading causes of death in critically ill patients with COVID-19 and blood purification therapies have a role to immunomodulate the excessive inflammatory response and improve clinical results. One of the devices designed for these therapies is the oXiris® filter, allowing to perform renal replacement therapy combined with selective adsorption of endotoxins and cytokines. We report a 55-year-old male with COVID who developed a septic shock secondary to a sepsis caused by Pseudomona aeruginosa, refractory to the usual management. A veno-venous continuous hemofiltration was started using the oXiris® filter for 48 hours. Subsequently, there was an improvement in clinical perfusion parameters and a reduction in inflammatory markers. The patient was discharged from the intensive care one month later |
| Disciplinas: | Medicina |
| Palabras clave: | Virus, Terapéutica y rehabilitación, COVID-19, Choque séptico, Terapia de reemplazo renal continuo, Síndrome de liberación de citocinas |
| Keyword: | Virus, Therapeutics and rehabilitation, COVID-19, Septic shock, Continuous renal replacement therapy, Cytokines release syndrome |
| Texto completo: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
